<?xml version="1.0" encoding="utf-8"?>
<publicwhip>

<spmotion spid="S3M-7525" date="2010-12-02" filename="day-bb-10_bb-12-02f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-10/bb-12-02f.htm">
 *S3M-7525 Jackie Baillie: Preventing Sexually Transmitted Infection—That the Parliament expresses its deep concern at the continuing increase in the number of cases of genital warts reported by Health Protection Scotland and NHS Information Services Division; notes the support of professional and patient organisations including fpa, the Terence Higgins Trust, the Royal Society for Public Health, the Medical Foundation for AIDS and Sexual Health and the British Association for Sexual Health and HIV for the introduction of the quadrivalent human papillomavirus (HPV) vaccine to help protects against cervical cancer and genital warts that is already used across mainland Europe, and calls on the Scottish Government and NHS Scotland to ensure that they bring their influence to bear to ensure that decisions taken at UK level that affect the HPV vaccination programme in Scotland take into account the opportunity offered by a quadrivalent vaccine to prevent both cervical cancer and genital warts. 
</spmotion>

<spmotion spid="S3M-7525" date="2010-12-06" filename="day-bb-10_bb-12-06f.htm" url="http://www.scottish.parliament.uk/business/businessBulletin/bb-10/bb-12-06f.htm">
 S3M-7525 Jackie Baillie: Preventing Sexually Transmitted Infection—That the Parliament expresses its deep concern at the continuing increase in the number of cases of genital warts reported by Health Protection Scotland and NHS Information Services Division; notes the support of professional and patient organisations including fpa, the Terence Higgins Trust, the Royal Society for Public Health, the Medical Foundation for AIDS and Sexual Health and the British Association for Sexual Health and HIV for the introduction of the quadrivalent human papillomavirus (HPV) vaccine to help protects against cervical cancer and genital warts that is already used across mainland Europe, and calls on the Scottish Government and NHS Scotland to ensure that they bring their influence to bear to ensure that decisions taken at UK level that affect the HPV vaccination programme in Scotland take into account the opportunity offered by a quadrivalent vaccine to prevent both cervical cancer and genital warts. Supported by: Jamie Hepburn*, Marlyn Glen* 
</spmotion>

</publicwhip>
